To summarize, our findings indicate that KMT2A, KMT2C, KMT2D, and KMT2H are more likely to inhibit tumor occurrence, whereas other KMT2s are more likely to promote tumor occurrence and are generally associated with poor prognosis. This evidence concerns the gene KMT2A and neoplasm.